Paclitaxel Kabi 6 mg/ml koncentrátum oldatos infúzióhoz

DRUG2 trials

Sponsors

Institut Curie, Stichting Amsterdam UMC

Conditions

Advanced stage NSCLCBreast cancer

Phase 1

"FAP-IT" 68Ga-FAPI-46 PET/CT for predicting histological response to neoadjuvant chemo-immunotherapy in triple-negative breast cancer

RecruitingCTIS2023-507860-37-00

Institut CurieBreast cancer

Start: 2024-10-14Target: 300Updated: 2025-11-10

Phase 3

Pembrolizumab Alone versUs pembrolizumab-chemotherapy in first LInE NSCLC (PAULIEN)

CompletedCTIS2024-516581-11-00

Stichting Amsterdam UMCAdvanced stage NSCLC

End: 2025-01-17Target: 84Updated: 2024-11-08